Vaccinex, Inc.

Please note: The information displayed on this page might be outdated.
Vaccinex, Inc.: Vaccinex is a privately-held, clinical-stage biotechnology company. Its lead product, pepinemab, is an antibody against semaphorin 4D, a novel immunotherapy target to modulate immune response to solid tumors and chronic inflammation that drives neurodegenerative diseases. Vaccinex has an ongoing Phase 2 trial in non-small cell lung cancer (NSCLC) of pepinemab in combination with Merck KGaA’s avelumab, an immune checkpoint inhibitor, and an advanced Phase 2 trial of single agent pepinemab in Huntington’s Disease.
Based in...
US - Middle Atlantic
Public, USA
Market Cap
1895 Mt. Hope Avenue
Rochester, NY 14620
United States

Company Participants at Solebury Trout Corporate Access Calls - May 11&12

  • Maurice Zauderer, Ph.D., President & CEO

Top 10 Holders of Vaccinex, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Vanguard Group, Inc. (Subfiler) 1.09 244,250 0.64 13F 3/31/21
The Vanguard Group, Inc. 0.86 244,250 0.64 Funds 4/30/21
Susquehanna Securities LLC 0.49 109,586 0.29 13F 3/31/21
Telemetry Investments LLC 0.47 105,000 0.28 13F 3/31/21
Geode Capital Management LLC 0.29 65,331 0.17 13F 3/31/21
Citadel LP 0.29 63,814 0.17 13F 3/31/21
Tower Research Capital LLC 0.24 53,780 0.14 13F 3/31/21
Marshall Wace LLP 0.19 43,215 0.11 13F 3/31/21
Oppenheimer & Co., Inc. 0.19 42,951 0.11 13F 3/31/21
UBS Group AG (13f Subfiler) 0.13 28,708 0.08 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.